Related references
Note: Only part of the references are listed.Synthesis and activity of novel indirubin derivatives
Bin Sun et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2021)
Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer
Hyo Jeong Lee et al.
PHARMACEUTICALS (2021)
Indirubin-3′-monoxime induces paraptosis in MDA-MB-231 breast cancer cells by transmitting Ca2+ from endoplasmic reticulum to mitochondria
Matharage Gayani Dilshara et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
7-Hydorxyindirubin is capable of specifically inhibiting anticancer drug-induced YB-1 nuclear translocation without showing cytotoxicity in HepG2 hepatocellular carcinoma cells
Toru Tanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins
Mirijam Schaefer et al.
CANCERS (2021)
Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia
Pyeonghwa Jeong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Sabrina Dallavalle et al.
DRUG RESISTANCE UPDATES (2020)
Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer
Ayed A. Dera et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Design, synthesis, structure, in vitro cytotoxic activity evaluation and docking studies on target enzyme GSK-3β of new indirubin-3'-oxime derivatives
Nguyen Trong Dan et al.
SCIENTIFIC REPORTS (2020)
Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy
Zhaohui Li et al.
AMB EXPRESS (2020)
Design, synthesis and evaluation of novel indirubin-based N- hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents
Duong Tien Anh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with in vitro Anti-Tumor Effects
Karyn Muzinga Ndolo et al.
BIOMOLECULES & THERAPEUTICS (2019)
A novel indirubin derivative that increases somatic cell plasticity and inhibits tumorigenicity
Woong-Hee Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Inhibitory effects of indirubin-3′-monoxime against human osteosarcoma
Yi Zhang et al.
IUBMB LIFE (2019)
Rational combinations of indirubin and arylidene derivatives exhibit synergism in human non-small cell lung carcinoma cells
Prasanna Rajagopalan et al.
JOURNAL OF FOOD BIOCHEMISTRY (2019)
Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3′-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3′-oxime (7BIO)
Micaela R. Scobie et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
p53-Mediated Oxidative Stress Enhances Indirubin-3′-Monoxime-Induced Apoptosis in HCT116 Colon Cancer Cells by Upregulating Death Receptor 5 and TNF-Related Apoptosis-Inducing Ligand Expression
Matharage Gayani Dilshara et al.
ANTIOXIDANTS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Indirubin 3′-Oxime Inhibits Migration, Invasion, and Metastasis In Vivo in Mice Bearing Spontaneously Occurring Pancreatic Cancer via Blocking the RAF/ERK, AKT, and SAPK/JNK Pathways
Yoshimi Ichimaru et al.
TRANSLATIONAL ONCOLOGY (2019)
Chemical characterization and biological activity data for a novel indirubin derivative, LDD-1819
Woong-Hee Kim et al.
DATA IN BRIEF (2019)
Synthesis of new indirubin derivatives and their in vitro anticancer activity
Dan Trong Nguyen et al.
CHEMICAL PAPERS (2019)
Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
Hyo Jeong Lee et al.
ONCOTARGET (2018)
Indirubin 3′-oxime inhibits anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells
Toru Tanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine
Lakshmi Mohan et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents
Jing Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Mechanism responsible for inhibitory effect of indirubin 3′-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells
Toru Tanaka et al.
EXPERIMENTAL CELL RESEARCH (2018)
Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells
Zhuohong Li et al.
ONCOTARGETS AND THERAPY (2018)
Indirubin-3′-oxime suppresses human cholangiocarcinoma through cell-cycle arrest and apoptosis
Ming-Yang Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist
Samantha C. Faber et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway
Lihong Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells
Kunping Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule
Xinlai Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells
Xiaowei Zhang et al.
MOLECULAR THERAPY (2017)
Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression
Manoela Viar Fogaca et al.
PHARMACEUTICAL BIOLOGY (2017)
Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells
Karyn Muzinga Ndolo et al.
IMMUNE NETWORK (2017)
5-Bromoindirubin 3′-(O-oxiran-2-ylmethyl)oxime: A long-acting anticancer agent and a suicide inhibitor for epoxide hydrolase
Yoshimi Ichimaru et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3′-oxime and 5-methoxyindirubin 3′-oxime in vitro and in vivo
Makoto Sano et al.
CANCER LETTERS (2017)
Small molecule screen identifies differentiation-promoting compounds targeting genetically diverse acute myeloid leukaemia
Aurelie Baudet et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
5-diphenylacetamido-indirubin-3-oxime as a novel mitochondria-targeting agent with anti-leukemic activities
Ju Han Song et al.
MOLECULAR CARCINOGENESIS (2016)
Indirubin 3′-Epoxide Induces Caspase-Independent Cell Death in Human Neuroblastoma
Masahiro Kurita et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening
Myoung Eun Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Indirubin, a component of Ban-Lan-Gen, activates CYP3A4 gene transcription through the human pregnane X receptor
Takeshi Kumagai et al.
DRUG METABOLISM AND PHARMACOKINETICS (2016)
Cell Death Induction by the Indirubin Derivative 7BIO and the BH3 Mimetic Drugs ABT-737 and GX15-070 in Medullary Thyroid Carcinoma Cells
M. Broecker-Preuss et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2016)
Natural-Based Indirubins Display Potent Cytotoxicity toward Wild Type and T315I-Resistant Leukemia Cell Lines
Nicolas Gaboriaud-Kolar et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Indirubin 3′-(O-oxiran-2-ylmethyl)oxime: A novel anticancer agent
Yoshimi Ichimaru et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of novel indirubin-3′-monoxime derivatives as potent inhibitors against CDK2 and CDK9
Lei Yan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Cell migration in paediatric glioma; characterisation and potential therapeutic targeting
J. V. Cockle et al.
BRITISH JOURNAL OF CANCER (2015)
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases
Tina Blazevic et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Indirubin derivatives: a patent review (2010-present)
Nicolas Gaboriaud-Kolar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Enhancing effects of indirubin on the arsenic disulfide-induced apoptosis of human diffuse large B-cell lymphoma cells
Ling Wang et al.
ONCOLOGY LETTERS (2015)
7,7′-Diazaindirubin-A small molecule inhibitor of casein kinase 2 in vitro and in cells
Xinlai Cheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Indirubin Derivative 6BIO Suppresses Metastasis
Simone Braig et al.
CANCER RESEARCH (2013)
Physicochemical characterization and in vitro permeation of an indirubin derivative
Nasim. Heshmati et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Vibrational spectra, DFT calculations, and conformations of 5′-chloro-1-isopropyl-7-azaindirubin-3′-oxime
Timothy J. Robbins et al.
JOURNAL OF MOLECULAR STRUCTURE (2013)
Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells
Sangkil Nam et al.
MOLECULAR ONCOLOGY (2013)
5′-OH-5-nitro-Indirubin oxime (AGM130), an Indirubin derivative, induces apoptosis of Imatinib-resistant chronic myeloid leukemia cells
Woo-Seok Kim et al.
LEUKEMIA RESEARCH (2013)
Indirubin-3′-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells
Ming-Yang Lee et al.
ONCOLOGY REPORTS (2013)
Synthesis and antiproliferative activity of selenoindirubins and selenoindirubin-N-glycosides
Friedrich Erben et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
An Indirubin Derivative, Indirubin-3′-Monoxime Suppresses Oral Cancer Tumorigenesis through the Downregulation of Survivin
Wan-Yu Lo et al.
PLOS ONE (2013)
Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases
Vassilios Myrianthopoulos et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Induction of discrete apoptotic pathways by bromo-substituted indirubin derivatives in invasive breast cancer cells
Katerina A. Nicolaou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
An indirubin derivative, E804, exhibits potent angiosuppressive activity
Yuk-Kit Chan et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Indirubin derivative E804 inhibits angiogenesis
Eun-Kyung Shin et al.
BMC CANCER (2012)
A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling
Lucy Liu et al.
CANCER BIOLOGY & THERAPY (2012)
Inhibition of Plk1 and Pin1 by 5′-nitro-indirubinoxime suppresses human lung cancer cells
Hyo-Eun Yoon et al.
CANCER LETTERS (2012)
Water-Soluble Cationic Derivatives of Indirubin, the Active Anticancer Component from Indigo naturalis
Werner Ginzinger et al.
CHEMISTRY & BIODIVERSITY (2012)
Indirubin Derivatives Modulate TGFβ/BMP Signaling at Different Levels and Trigger Ubiquitin-Mediated Depletion of Nonactivated R-Smads
Xinlai Cheng et al.
CHEMISTRY & BIOLOGY (2012)
Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes
Wan-Ling Hsieh et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2012)
Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling
Sangkil Nam et al.
MOLECULAR ONCOLOGY (2012)
From Tyrian Purple to Kinase Modulators: Naturally Halogenated Indirubins and Synthetic Analogues
Konstantina Vougogiannopoulou et al.
PLANTA MEDICA (2012)
Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative-Enhancement of both extrinsic and intrinsic apoptosis pathways
Anja Berger et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Synthesis of methoxy- and bromo-substituted indirubins and their activities on apoptosis induction in human neuroblastoma cells
Hiroaki Saito et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
5′-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin β1/FAK/Akt signaling
Soo-A Kim et al.
CANCER LETTERS (2011)
6-Bromoindirubin-3′-Oxime Inhibits JAK/STAT3 Signaling and Induces Apoptosis of Human Melanoma Cells
Lucy Liu et al.
CANCER RESEARCH (2011)
Indirubins Decrease Glioma Invasion by Blocking Migratory Phenotypes in Both the Tumor and Stromal Endothelial Cell Compartments
Shante P. Williams et al.
CANCER RESEARCH (2011)
Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations
Patricia Rivest et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Hydrothermal Syntheses and Crystal Structures of Two Layered Nickel(II) Coordination Polymers Based on 1,2,3-Benzenetricarboxylic Acid
Wang Jing et al.
CHINESE JOURNAL OF CHEMISTRY (2011)
Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell
Xiaoli Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Neuroprotective effects of the beta-catenin stabilization in an oxygen- and glucose-deprived human neural progenitor cell culture system
Marco Skardelly et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2011)
Indirubin-3′-Monoxime, a Derivative of a Chinese Antileukemia Medicine, Inhibits Angiogenesis
Jin-Kyung Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
5′-Nitro-Indirubinoxime Inhibits Epidermal Growth Factor- and Phorbol Ester-Induced AP-1 Activity and Cell Transformation Through Inhibition of Phosphorylation of Pin1
Prem Khanal et al.
MOLECULAR CARCINOGENESIS (2011)
5′-Nitro-indirubinoxime induces G1 cell cycle arrest and apoptosis in salivary gland adenocarcinoma cells through the inhibition of Notch-1 signaling
Ji-Hye Yoon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
Synthesis and cytotoxicity of novel indirubin-5-carboxamides
Xinlai Cheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells
Soo Jeong Choi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis of Thia-Analogous Indirubin N-Glycosides and their Influence on Melanoma Cell Growth and Apoptosis
Manfred Kunz et al.
CHEMMEDCHEM (2010)
Synthesis and CDK2 kinase inhibitory activity of 7/7′-azaindirubin derivatives
Zhao Hui Wang et al.
CHINESE CHEMICAL LETTERS (2010)
Effects of lndirubin Derivatives on the FLT3 Activity and Growth of Acute Myeloid Leukemia Cell Lines
Sun-Young Han et al.
DRUG DEVELOPMENT RESEARCH (2010)
Indirubin shows anti-angiogenic activity in an in vivo zebrafish model and an in vitro HUVEC model
Deepa Alex et al.
JOURNAL OF ETHNOPHARMACOLOGY (2010)
5,5′-Substituted Indirubin-3′-oxime Derivatives as Potent Cyclin-Dependent Kinase Inhibitors with Anticancer Activity
Soo-Jeong Choi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention
Nina Korzeniewski et al.
MOLECULAR CANCER (2010)
Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells
Thiruvanmiyoor Ravichandran Kameswaran et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Synthesis and kinase inhibitory activity of novel substituted indigoids
Anne Beauchard et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Synthesis and evaluation of functionalized isoindigos as antiproliferative agents
Xi Kai Wee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Novel small molecule activators of β-catenin-mediated signaling pathway: structure-activity relationships of indirubins
Eun-Jung Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
5′-nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells
Soo-A Kim et al.
CANCER LETTERS (2009)
Synthesis and antitumor activity of 7-azaindirubin
Zhao Hui Wang et al.
CHINESE CHEMICAL LETTERS (2009)
Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component
Yin-Ku Lin et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2009)
The cytotoxicity to leukemia cells and antiviral effects of Isatis indigotica extracts on pseudorabies virus
Shih-Ling Hsuan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
Synthesis and Antiproliferative Activity of 7-Azaindirubin-3′-oxime, a 7-Aza Isostere of the Natural Indirubin Pharmacophore
Marina Kritsanida et al.
JOURNAL OF NATURAL PRODUCTS (2009)
Indirubin derivatives inhibit malignant lymphoid cell proliferation
Amel Chebel et al.
LEUKEMIA & LYMPHOMA (2009)
7-Bromoindirubin-3′-oxime uncovers a serine protease-mediated paradigm of necrotic cell death
Judit Ribas et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Critical role of Bid and Bax in indirubin-3′-monoxime-induced apoptosis in human cancer cells
Jie Shi et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Synthesis of indirubin-N′-glycosides and their anti-proliferative activity against human cancer cell lines
Stefanie Libnow et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Indirubin-3′-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling
Mi-Jee Lee et al.
CANCER LETTERS (2008)
Soluble 3′,6-Substituted Indirubins with Enhanced Selectivity toward Glycogen Synthase Kinase-3 Alter Circadian Period
Konstantina Vougogiannopoulou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia
Lan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Comparative study of aryl hydrocarbon receptor ligand activities of six chemicals in vitro and in vivo
Kazumi Sugihara et al.
ARCHIVES OF TOXICOLOGY (2008)
Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish
T. Cameron Tran et al.
CANCER RESEARCH (2007)
The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice:: potential implication for the treatment of autoimmune diseases
Aijun Zhang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Inverse in silico screening for identification of kinase inhibitor targets
Stefan Zahler et al.
CHEMISTRY & BIOLOGY (2007)
Indirubin-3′-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK
Y. Zhen et al.
ONCOGENE (2007)
An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins
Vassilios Myrianthopoulos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Antitumor activity of novel indirubin derivatives in rat tumor model
Soo-A Kim et al.
CLINICAL CANCER RESEARCH (2007)
7-bromoindirubin-3′-oxime induces caspase-independent cell death
J. Ribas et al.
ONCOGENE (2006)
Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced differentiation of HL-60 leukemia cells
Seung Hyun Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
First synthesis of indirubin N-glycosides (red sugars)
Stefanie Libnow et al.
TETRAHEDRON LETTERS (2006)
Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-κB signaling pathway
Gautam Sethi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
3′-substituted 7-halogenoindirubins, a new class of cell death inducing agents
Yoan Ferandin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities
MJ Moon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Indirubin, a Chinese anti-leukaemia drug, promotes neutrophilic differentiation of human myelocytic leukaemia HL-60 cells
K Suzuki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells
JW Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells
S Nam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors
R Jautelat et al.
CHEMBIOCHEM (2005)
Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases
P Polychronopoulos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin
J Adachi et al.
TOXICOLOGICAL SCIENCES (2004)
Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells
NK Mak et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine
G Eisenbrand et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Structural characterization of the GSK-3β active site using selective and non-selective ATP-mimetic inhibitors
JA Bertrand et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Small molecules as inhibitors of cyclin-dependent kinases
A Huwe et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
GSK-3-selective inhibitors derived from Tyrian purple indirubins
L Meijer et al.
CHEMISTRY & BIOLOGY (2003)
Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China
ZJ Xiao et al.
LEUKEMIA & LYMPHOMA (2002)
Identification of an indigo precursor from leaves of Isatis tinctoria (Woad)
T Maugard et al.
PHYTOCHEMISTRY (2001)
Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine
J Adachi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest
E Damiens et al.
ONCOGENE (2001)
Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate
TG Davies et al.
STRUCTURE (2001)
Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells
D Marko et al.
BRITISH JOURNAL OF CANCER (2001)
Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease -: A property common to most cycline-dependent kinase inhibitors?
S Leclerc et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity
T Kunikata et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
